Pharma Journalist -

Chairman of the 2019 Biosimilars Conference, Michel Mikhail, International Expert Regulatory Affairs, Global Expert of Biosimilars, invites biosimilar experts to attend the next…
Read More...

Exelixis, Inc. announced its partner Daiichi Sankyo Company, Limited has launched MINNEBRO (esaxerenone) tablets as a treatment for patients with hypertension in Japan. With Daiichi…
Read More...

ElevateBio announced operations to create and build a broad portfolio of cell and gene therapy companies through partnerships with leading academic researchers, medical centers and…
Read More...

Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to POMALYST (pomalidomide) for the treatment of patients with…
Read More...

Geoff Smith from De Montford University will be speaking at SMi’s 7th Annual Lyophilisation Conference which will take place in London on 3rd – 4th June 2019. He will be speaking on the…
Read More...

  After the three successful ACI's European Prefilled Syringes Summit, we are pleased to inform you that the 4th edition will take place this month on the 9th & 10th October in…
Read More...

Recipharm, the contract development and manufacturing organisation (CDMO), has launched its end-to-end inhalation offering to provide customers with a fully integrated service from…
Read More...

BioNTech SE announced the acquisition of antibody assets and infrastructure from San Diego-based MabVax Therapeutics Holding, a clinical-stage oncology drug development company.…
Read More...

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Tarceva (erlotinib) tablets, 100 and 150 mg, in the U.S. Erlotinib Tablets are a kinase inhibitor…
Read More...

Adimab announced the expansion of an earlier multi-target research agreement with Regeneron Pharmaceuticals. Adimab and Regeneron commenced an initial agreement in December 2014,…
Read More...